When SGK1 expressing cells are treated with PI3Kα and PDK1 inhibitors, both AKT and SGK1 are inhibited, inducing tumour regression as a result of FOXO3 activation and mTORC1 inhibition45. The gene discussed is FOXO3; the disease is neoplasm.